SilverStream Medical develops proprietary solutions for the global chronic wound care market. Its products are designed to quickly and effectively clean, moisturize, and soothe all types of wounds, from small cuts and burns to non-healing chronic wounds, while destroying biofilm and promoting granulation.
Designed for use in hospitals, outpatient care, and long-term and home health agencies, the company’s products can substantially shorten wound healing time while reducing pain and suffering.
SilverStream Medical products have been authorized by the U.S. FDA and in over 20 countries worldwide, including India (CDSCO) and Israel (AMAR), for the management of stage 1-4 pressure ulcers, stasis ulcers, diabetic foot ulcers, post-surgical wounds, first- and second-degree burns, cuts, abrasions, minor skin irritations, and other wounds.
SilverStream is looking for scaleup growth capital from savvy investors interested in Israeli-made medical technologies. They are also looking for local partners to develop IP in post-op wound care and supplier partners for national distribution deals.
Israel Trade and Economic Commission in Sydney, Australia 